Clinical Trial Update: Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan) [NA]

View source ↗

Summary

A China-based clinical trial evaluating Varian's ProBeam360° proton therapy system for solid tumors has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Tumor, Solid | NA | Status: COMPLETED | Results posted: 2025-12-15